Morgan Stanley Global Endurance Portfolio Class A (MSJAX)
Fund Assets | 2.08M |
Expense Ratio | 1.35% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 0.24 |
Dividend Yield | 1.35% |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | n/a |
Previous Close | 16.69 |
YTD Return | -0.06% |
1-Year Return | 7.78% |
5-Year Return | 60.19% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 33 |
Inception Date | Dec 31, 2018 |
About MSJAX
MSJAX was founded on 2018-12-31. The Fund's investment strategy focuses on Global with 1.35% total expense ratio. The minimum amount to invest in Morgan Stanley Institutional Fund, Inc: Global Endurance Portfolio; Class A Shares is $1,000 on a standard taxable account. Morgan Stanley Institutional Fund, Inc: Global Endurance Portfolio; Class A Shares seeks long-term capital appreciation. MSJAX invests primarily in equity securities of established and emerging companies located throughout the world, with rising returns on invested capital, above-average business visibility, strong free cash flow generation and an attractive risk/reward.
Performance
MSJAX had a total return of 7.78% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.40%.
Top 10 Holdings
62.99% of assetsName | Symbol | Weight |
---|---|---|
Victoria PLC | VCP.L | 16.80% |
Appian Corporation | APPN | 12.27% |
Morgan Stanley InstlLqdty TrsSecs Instl | MSUXX | 9.25% |
Domino's Pizza Group plc | DOM | 5.13% |
Babcock International Group PLC | BAB | 3.76% |
Lithia Motors, Inc. | LAD | 3.49% |
Avadel Pharmaceuticals plc | AVDL | 3.29% |
Roivant Sciences Ltd. | ROIV | 3.07% |
Royalty Pharma plc | RPRX | 2.98% |
Delivery Hero SE | DHER | 2.96% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 15, 2023 | $0.24204 | Dec 15, 2023 |
Dec 17, 2021 | $1.29801 | Dec 17, 2021 |
Dec 16, 2020 | $0.81513 | Dec 16, 2020 |